Covid19 News: Oxford's Coronavirus Vaccine Works for Both Elderly and Adults

Covid19 News: Oxford's Coronavirus Vaccine Works for Both Elderly and Adults

One of the good news among the worldwide quorum due to the worldwide coronavirus (covid19) infection is that the corona vaccine developed by the UK's Oxford University and pharmaceutical company AstraZeneca is showing good effects on both adults and adults.

According to reports in foreign media, after giving Oxford's corona vaccine, the elderly have antibodies and T cells, which enable the individual to beat the coronavirus. Analysis of data from the blood reports released in July of elderly volunteers involved in the trial of the corona vaccine revealed the fact that they had developed a high degree of immunity after giving the vaccine. Apart from this, it also showed a good influence on volunteers in the age group of 18 to 55 years.

AstraZeneca said today that it is encouraging that good immunity against the coronavirus has developed in both the elderly and adults and the side effects of this vaccine have been less seen on the elderly. This figure shows the safety and efficacy of our company's corona vaccine. This report will soon be published in the medical journal.